India’s federal food regulator issued a notice to the joint venture between Dr. Reddy’s Laboratories Ltd. and Nestle India Ltd. for misleading and ambiguous claims about its GLP-1 supplement.
Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) News
Latest headlines that mention RDY, newest first · each headline opens the original publisher
- Last price
- $13.23
- Day change
- +0.30%
- Next earnings
- 2026-10-23
RDY headlines
latest coverageNot much coverage yet. RDY has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Dr. Reddy’s Laboratories Ltd. expects its generic anti-obesity drug to shore up growth in the six months through March after it resolves an impurity issue with the key ingredient and resumes supply in early November.
RDY news alerts
Get an alert by email or push when a new headline mentions RDY.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.